ONESOURCE SPECL PHARMA L (ONESOURCE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 2007, OneSource Specialty Pharma Ltd is in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. It also offers end-to-end CDMOservices across all phases of pre-clinicaland clinical development and commercialsupply of…

ONESOURCEUpdated 30 Aug 2026, 22:47

Onesource Specl Pharma L

Market Cap

₹17,570Cr.

Current Price

₹1,532

High / Low

₹1,925/1,057

Stock P/E

331

ROE0.45%
ROCE2.06%
Book Value₹519
Face Value₹1.00
Dividend Yield0.00%

About

Incorporated in 2007, OneSource Specialty Pharma Ltd is in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. It also offers end-to-end CDMOservices across all phases of pre-clinicaland clinical development and commercialsupply of biologics[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3810135118124191
Inventory Days871,7202,354665233360
Days Payable7584081,606419143330
Cash Conversion Cycle-6331,414784363214221
Working Capital Days-2,423-1,288-6,731-873-49-41
ROCE %-10%-12%-12%6%2%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 30 August 2026 at 22:47


Designed & Shipped by Harshit Bansal